0.81
price up icon3.58%   0.028
after-market 시간 외 거래: .81
loading
전일 마감가:
$0.782
열려 있는:
$0.7812
하루 거래량:
119.04K
Relative Volume:
0.16
시가총액:
$9.16M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.94%
1개월 성능:
+8.87%
6개월 성능:
-91.29%
1년 성능:
-99.50%
1일 변동 폭
Value
$0.7812
$0.8184
1주일 범위
Value
$0.76
$0.8649
52주 변동 폭
Value
$0.375
$215.31

AEON Biopharma Inc. Stock (AEON) Company Profile

Name
명칭
AEON Biopharma Inc.
Name
전화
(949) 354-6499
Name
주소
5 Park Plaza, Suite 1750, Irvine
Name
직원
9
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
AEON's Discussions on Twitter

AEON을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AEON
AEON Biopharma Inc.
0.81 9.43M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-08-18 개시 H.C. Wainwright Buy

AEON Biopharma Inc. 주식(AEON)의 최신 뉴스

pulisher
Jul 20, 2025

What drives AEON Biopharma Inc. stock pricePhenomenal wealth increase - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Is AEON Biopharma Inc. a good long term investmentFree Stock Market Beginners Guide - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

AEON Biopharma Inc. Stock Analysis and ForecastGame-changing capital returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about AEON Biopharma Inc. stockDynamic portfolio growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

why aeon biopharma inc. stock attracts strong analyst attentionProven Return Strategy Execution - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

what makes aeon biopharma inc. stock price move sharplyROI Focused Stock Calls - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why AEON Biopharma Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes AEON Biopharma Inc. stock price move sharplyFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How AEON Biopharma Inc. stock performs during market volatilitySmart Return Focused Trading - Newser

Jul 15, 2025
pulisher
Jun 18, 2025

AEON Biopharma (NASDAQ:AEON) Trading Down 10.2% – Should You Sell? - Defense World

Jun 18, 2025
pulisher
Jun 13, 2025

AEON Biopharma Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

AEON Biopharma, Inc. (NASDAQ:AEON) Short Interest Update - Defense World

Jun 12, 2025
pulisher
May 27, 2025

AEON Biopharma Soars 13.67% on CEO Appointment, Talent Grants - AInvest

May 27, 2025
pulisher
May 24, 2025

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times

May 24, 2025
pulisher
May 23, 2025

AEON Biopharma Expands Team with 100K+ Stock Awards: Inside the Biotech's Latest Hiring Move - Stock Titan

May 23, 2025
pulisher
May 21, 2025

Aeon Biopharma Reports Positive Q1 2025 Earnings - TipRanks

May 21, 2025
pulisher
May 20, 2025

AEON Biopharma Releases New Corporate Presentation - TipRanks

May 20, 2025
pulisher
May 19, 2025

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - The Manila Times

May 19, 2025
pulisher
May 19, 2025

AEON Biopharma to Present Corporate Overview at Aegis Capital Corp. 2025 Virtual Conference - Nasdaq

May 19, 2025
pulisher
May 19, 2025

AEON Biopharma Unveils Next-Gen Botulinum Toxin Therapies: CEO Details Multi-Indication Pipeline - Stock Titan

May 19, 2025
pulisher
May 14, 2025

AEON Biopharma Advances Biosimilar Product Development and Appoints New CEO - Nasdaq

May 14, 2025
pulisher
May 14, 2025

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

May 14, 2025
pulisher
May 14, 2025

New AEON CEO Targets $3.3B Botox Market with FDA-Ready Biosimilar Development Plan - Stock Titan

May 14, 2025
pulisher
May 11, 2025

AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

Closing Bell Recap: AEON Biopharma Inc (AEON) Ends at 0.75, Reflecting a -11.76 Downturn - DWinneX

May 09, 2025
pulisher
May 06, 2025

AEON Biopharma Inc (AMEX: AEON) Stock: Investors Need To Know This - Stocksregister

May 06, 2025
pulisher
May 05, 2025

Is AEON Biopharma Inc’s (AMEX:AEON) Stock On The Decline? - Stocksregister

May 05, 2025
pulisher
Apr 26, 2025

AEON Biopharma gets NYSE American nod for compliance plan - Investing.com Australia

Apr 26, 2025
pulisher
Apr 25, 2025

AEON Biopharma gets NYSE American nod for compliance plan By Investing.com - Investing.com Canada

Apr 25, 2025
pulisher
Apr 25, 2025

AEON Biopharma Says NYSE American Accepts Plan to Regain Compliance - marketscreener.com

Apr 25, 2025
pulisher
Apr 25, 2025

AEON Biopharma Receives Acceptance from NYSE American to Regain Compliance with Listing Standards - Nasdaq

Apr 25, 2025
pulisher
Apr 25, 2025

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

NYSE American Grants AEON Biopharma 2-Year Lifeline to Meet Listing Requirements - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

AEON Biopharma’s Fight to Stay Listed: A High-Stakes Gamble? - AInvest

Apr 25, 2025
pulisher
Apr 24, 2025

What was AEON Biopharma Inc (AEON)’s performance in the last session? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Analyzing the Impact of Earnings Reports on AEON Biopharma Inc Inc. (AEON) Price Performance - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Who’s Hired? Botox Biosimilar Developer Aeon Takes CEO From Rival Revance - insights.citeline.com

Apr 24, 2025
pulisher
Apr 22, 2025

AEON Biopharma, Inc. Announces Executive Changes, Effective as of April 4, 2025 - marketscreener.com

Apr 22, 2025

AEON Biopharma Inc. (AEON) 재무 분석

AEON Biopharma Inc. (AEON)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):